跳至主要内容
临床试验/NCT02546583
NCT02546583已完成1 期

Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure

Yale University1 个研究点 分布在 1 个国家目标入组 458 人开始时间: 2015年8月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
458
试验地点
1
主要终点
Accuracy of sodium prediction equation in predicting suboptimal natriuretic response to a dose of diuretics

研究概览

简要总结

Effective diuresis is the primary goal of most acute decompensated heart failure hospitalizations, but diuretic resistance is common and our ability to detect it is limited. Further, there are therapeutically distinct groups of diuretic-resistant patients. These are not easily distinguished using currently available methods, leading to trial-and-error based treatment that promotes lengthy hospitalizations.

The aims of this study are:

  1. To develop inexpensive and efficient tools to predict diuretic response
  2. To understand the prevalence of therapeutically targetable mechanisms of diuretic resistance using endogenous lithium clearance
  3. To develop methodology to differentiate diuretic resistance mechanisms using common/inexpensive laboratory tests
  4. To provide proof of concept that mechanistically tailored diuretic therapy can improve natriuresis

详细描述

This study is a minimal-risk observational open-label single center study with randomization between two standard of care interventions. Approximately 500 patients admitted to the hospital (Yale New Haven Health System) with a clinical diagnosis of heart failure will be enrolled in the overall study.

Patients will undergo sampling of their blood and collection of urine at a minimum of 4 timepoints (called "visits"), or a minimum of 5 in the interventional arm. Patients with a low urine sodium output (<100 mmol) on Visit 1 will be eligible for 1:1 randomization to either an increased dose of their Visit 1 loop diuretic or addition of IV chlorothiazide to their Visit 1 loop diuretic.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Increased Intravenous Loop Diuretic (Bumetanide or Furosemide)

Experimental

2.5x Visit 1 dose

干预措施: Increased Intravenous Bolus Loop Diuretic Dose (Bumetanide or Furosemide) (Drug)

Loop Diuretic (Bumetanide or Furosemide) + IV Chlorothiazide

Experimental

Loop diuretic (Bumetanide or Furosemide) dose remains the same as visit 1 dose but now with the addition of 500-1000 mg IV chlorothiazide

干预措施: IV Chlorothiazide (Drug)

结局指标

主要结局

Accuracy of sodium prediction equation in predicting suboptimal natriuretic response to a dose of diuretics

时间窗: 6 hours

Suboptimal Natriuretic Response is defined as a measured sodium output of \<100 mmol in the 6 hours following the dose of diuretic

Accuracy of prediction of mechanistic sub types of DR using universally available laboratory tests

时间窗: 6 hours

The relationship between the change in fractional excretion of potassium and sodium and the change in fractional excretion of endogenous lithium will be assessed in order to develop methodology to identify the etiology of DR using universally available laboratory tests.

Prevalence of mechanistic sub types of Diuretic Resistance (DR) as defined by cutoff values of change in fractional excretion of lithium

时间窗: 6 hours

Descriptions of the prevalence of the DR mechanisms at the different time points in the study will be reported.

Change in total 6-hour sodium output between observational and randomized intervention study days, compared between intervention groups

时间窗: 6 hours

Sodium output in response to a dose of diuretics will be measured via urine collection.

次要结局

  • Prediction of mechanistic sub types of DR(6 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验